CKW Financial Group’s Pfizer PFE Stock Holding History

CKW Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35K	Hold	1,475	–	–	﹤0.01%	84
2026 Q1	$42K	Hold	1,475	–	–	﹤0.01%	74
2025 Q4	$37K	Sell	1,475 -300	-17%	-$7.57K	﹤0.01%	81
2025 Q3	$48K	Hold	1,775	–	–	0.01%	77
2025 Q2	$44K	Sell	1,775 -275	-13%	-$6.41K	0.01%	80
2025 Q1	$50K	Buy	2,050 +1,144	+126%	+$29.9K	0.01%	81
2024 Q4	$24K	Buy	906 +500	+123%	+$13.6K	﹤0.01%	161
2024 Q3	$12K	Hold	406	–	–	﹤0.01%	174
2024 Q2	$11K	Hold	406	–	–	﹤0.01%	176
2024 Q1	$11K	Sell	406 -40	-9%	-$1.11K	﹤0.01%	175
2023 Q4	$13K	Buy	446 +16	+4%	+$484	﹤0.01%	177
2023 Q3	$14K	Sell	430 -50	-10%	-$1.77K	﹤0.01%	162
2023 Q2	$18K	Hold	480	–	–	﹤0.01%	160
2023 Q1	$20K	Hold	480	–	–	﹤0.01%	145
2022 Q4	$25K	Hold	480	–	–	﹤0.01%	143
2022 Q3	$21K	Hold	480	–	–	﹤0.01%	148
2022 Q2	$25K	Hold	480	–	–	﹤0.01%	142
2022 Q1	$25K	Hold	480	–	–	﹤0.01%	148
2021 Q4	$30K	Buy	480 +50	+12%	+$2.48K	﹤0.01%	148
2021 Q3	$18K	Buy	430 +50	+13%	+$2.21K	﹤0.01%	170
2021 Q2	$15K	Hold	380	–	–	﹤0.01%	184
2021 Q1	$14K	Hold	380	–	–	﹤0.01%	154
2020 Q4	$14K	Sell	380 -21	-5%	-$770	﹤0.01%	141
2020 Q3	$14K	Hold	401	–	–	﹤0.01%	135
2020 Q2	$13K	Hold	401	–	–	﹤0.01%	134
2020 Q1	$12K	Hold	401	–	–	﹤0.01%	130
2019 Q4	$15K	Hold	401	–	–	﹤0.01%	129
2019 Q3	$13K	Hold	401	–	–	﹤0.01%	126
2019 Q2	$16K	Hold	401	–	–	﹤0.01%	124
2019 Q1	$16K	Hold	401	–	–	﹤0.01%	142
2018 Q4	$17K	Hold	401	–	–	﹤0.01%	139
2018 Q3	$17K	Hold	401	–	–	﹤0.01%	143
2018 Q2	$14K	Hold	401	–	–	﹤0.01%	144
2018 Q1	$13K	Hold	401	–	–	﹤0.01%	124
2017 Q4	$14K	Hold	401	–	–	﹤0.01%	123
2017 Q3	$14K	Hold	401	–	–	﹤0.01%	127
2017 Q2	$13K	Hold	401	–	–	﹤0.01%	140
2017 Q1	$13K	Hold	401	–	–	﹤0.01%	126
2016 Q4	$12K	Hold	401	–	–	﹤0.01%	127
2016 Q3	$13K	Hold	401	–	–	﹤0.01%	131
2016 Q2	$13K	Hold	401	–	–	﹤0.01%	134
2016 Q1	$11K	Hold	401	–	–	﹤0.01%	126
2015 Q4	$12K	Sell	401 -2,391	-86%	-$75.2K	﹤0.01%	124
2015 Q3	$83K	Sell	2,792 -2,951	-51%	-$94.6K	0.03%	51
2015 Q2	$183K	Sell	5,743 -171	-3%	-$5.57K	0.07%	28
2015 Q1	$193K	Sell	5,914 -1,054	-15%	-$33.5K	0.08%	25
2014 Q4	$206K	Buy	6,968 +294	+4%	+$8.43K	0.09%	27
2014 Q3	$187K	Buy	6,674 +6,358	+2,012%	+$178K	0.08%	31
2014 Q2	$9K	Sell	316 -7,623	-96%	-$217K	﹤0.01%	314
2014 Q1	$243K	Buy	7,939 +1,054	+15%	+$31.4K	0.12%	22
2013 Q4	$200K	Buy	+6,885	New	+$200K	0.1%	28

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CKW Financial Group's PFE Position: Q2 2026 in Review

CKW Financial Group held its Pfizer (PFE) position steady in Q2 2026 at 1,475 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #84.

CKW Financial Group first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $243K in Q1 2014. 1,342 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

CKW Financial Group held 1,475 shares of Pfizer worth $35K as of Q2 2026.
CKW Financial Group left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of CKW Financial Group's portfolio in Q2 2026, its #84 holding.
CKW Financial Group first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
CKW Financial Group's Pfizer position peaked at $243K in Q1 2014.
1,342 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CKW Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.